Concepedia

S. Edgerton

SE

Statistics

Publications

5

Citations

659

H-Index

5

Active since

1991

Affiliations

Massachusetts General Hospital(Current)

S. Edgerton is an author at Massachusetts General Hospital specializing in cancer research, cell biology, and tumor biology.

Top concepts

Publications per year

1991–2004

5

Publications

5

Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer

Ann D. Thor, Shiyi Liu, S. Edgerton et al. · Journal of Clinical Oncology · 2000 · 173 citations

Stress Response Protein (srp-27) Determination in Primary Human Breast Carcinomas: Clinical, Histologic, and Prognostic Correlations

Ann D. Thor, Christopher C. Benz, Dan H. Moore et al. · JNCI Journal of the National Cancer Institute · 1991 · 151 citations

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study

David N. Louis, S. Edgerton, Ann D. Thor et al. · Acta Neuropathologica · 1991 · 146 citations

, , +9

Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional Phase II Trial

Karen L. Tedesco, Ann D. Thor, Douglas H. Johnson et al. · Journal of Clinical Oncology · 2004 · 111 citations

p53 mutations in benign breast tissue.

Robert C. Millikan, Barbara S. Hulka, Ann D. Thor et al. · Journal of Clinical Oncology · 1995 · 78 citations

1–5 of 5